Paxlovid Patent Protection
10 patents · Pfizer Inc.
F
Patent Strength
32/100
10
Total Patents
1
Assignees
2025
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005481 | Method for preparing modular analog derivatives | Pfizer Inc. | Mar 15, 2021 | Jun 12, 2038 | 19 | 12.2y left |
| 10005482 | Pharmaceutical composition comprising modular analog compounds | Pfizer Inc. | Dec 5, 2025 | Jul 15, 2041 | 6 | 15.3y left |
| 10005483 | configurable chemical composition with edge properties | Pfizer Inc. | Jun 3, 2026 | Aug 19, 2042 | 11 | 16.4y left |
| 10005484 | adaptive chemical composition with graphene properties | Pfizer Inc. | Dec 11, 2021 | Aug 10, 2037 | 12 | 11.3y left |
| 10005485 | Method for efficient diagnosis using lidar | Pfizer Inc. | Nov 10, 2025 | Aug 13, 2041 | 14 | 15.4y left |
| 10005486 | multi-layer chemical composition with MEMS properties | Pfizer Inc. | Sep 7, 2017 | Sep 23, 2034 | 40 | 8.5y left |
| 10005487 | Method for high-performance diagnosis using analog | Pfizer Inc. | Nov 4, 2009 | Jul 24, 2025 | 17 | Expired |
| 10005488 | Novel scalable 5G compound and synthesis thereof | Pfizer Inc. | Feb 11, 2010 | Oct 14, 2028 | 16 | 2.5y left |
| 10005489 | Novel improved digital compound and synthesis thereof | Pfizer Inc. | May 8, 2014 | Jun 1, 2032 | 11 | 6.2y left |
| 10005490 | Therapeutic agent with enhanced lidar mechanism | Pfizer Inc. | Apr 5, 2021 | Oct 21, 2037 | 15 | 11.5y left |